𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of a High Volume Screen to Identify Inhibitors of Endothelial Cell Activation

✍ Scribed by John W. Rice; Jefferson E. Davis; Robert M. Crowl; Patricia A. Johnston


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
107 KB
Volume
241
Category
Article
ISSN
0003-2697

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Application of a novel in silico high-th
✍ Catherine Joce; Joshua A. Stahl; Mitesh Shridhar; Mark R. Hutchinson; Linda R. W πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 447 KB

Increasing numbers of target protein structures available for computational studies makes the structure-based screening paradigm more attractive for initial hit indentification. We have developed a novel in silico screening methodology incorporating Molecular Mechanics (MM)/implicit solvent methods

A novel cell-free screen identifies a po
✍ Igor Landais; Alexandra Sobeck; Stacie Stone; Alexis LaChapelle; Maureen E. Hoat πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 616 KB

## Abstract The Fanconi Anemia (FA) DNA damage response pathway is involved in the processing of DNA interstrand crosslinks (ICLs). As such, inhibition of the FA pathway could chemosensitize FA‐competent tumor cells to commonly used ICL agents like cisplatin. Moreover, suppression of the FA pathway

Development of a CD28 Receptor Binding-B
✍ Chung-Her Jenh; Meng Zhang; Maria Wiekowski; Jimmy C. Tan; Xue-Dong Fan; Vinod H πŸ“‚ Article πŸ“… 1998 πŸ› Elsevier Science 🌐 English βš– 152 KB

CD28 is a T-cell costimulatory receptor which plays a pivotal role in antigen-induced T-cell response. We have developed a cell-free and scintillation-proximity assay-based screen to search for molecules that inhibit ligand binding to CD28. The assay was shown to be versatile and adaptable to automa